JAZZ
−$1.22M
8,000 sh @ $152
JAZZ
Jazz Pharmaceuticals plc
SEC CIK 1232524
$230.56
+39.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$7.1M
10 open-market
Net insider flow
−$7.1M
Net selling
Filings shown
143
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at JAZZ have sold a net $7.1M of stock (0 open-market buys vs 10 sells).
Largest recent trade: Cozadd Bruce C sold $6.76M of JAZZ, trimming their stake 9%.
Most active filer: Cozadd Bruce C, with 61 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for JAZZ, newest firstJAZZ
−$117.2K
931 sh @ $126
JAZZ
−$127K
1,009 sh @ $126
JAZZ
−$98.5K
726 sh @ $136
JAZZ
−$106.8K
787 sh @ $136
Advertisement
JAZZ
−$126.3K
715 sh @ $177
JAZZ
−$116.6K
660 sh @ $177
JAZZ
−$101.6K
714 sh @ $142
JAZZ
−$93.5K
685 sh @ $136
JAZZ
−$101.2K
697 sh @ $145
JAZZ
−$155.3K
863 sh @ $180
JAZZ
−$1.54M
31,166 sh @ $50
JAZZ
Sebulsky Alan, JAZZ's Director, spent $15.5K of their own money on 2,256 shares at $7, growing their stake 43%.
+$15.5K
2,256 sh @ $7
JAZZ
Sebulsky Alan, JAZZ's Director, spent $51.5K of their own money on 7,532 shares at $7, growing their stake 101%.
+$51.5K
7,532 sh @ $7
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $84.2K of their own money on 9,940 shares at $8.
+$84.2K
9,940 sh @ $8
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $90.6K of their own money on 10,724 shares at $8.
+$90.6K
10,724 sh @ $8
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $20.9K of their own money on 2,461 shares at $9.
+$20.9K
2,461 sh @ $9
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $2.5K of their own money on 300 shares at $8.
+$2.5K
300 sh @ $8
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $232.5K of their own money on 26,847 shares at $9, growing their stake 1%.
+$232.5K
26,847 sh @ $9
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $13.1K of their own money on 1,500 shares at $9.
+$13.1K
1,500 sh @ $9
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $65.2K of their own money on 7,449 shares at $9.
+$65.2K
7,449 sh @ $9
JAZZ
Bridger Management Llc, JAZZ's 10% owner, spent $356.4K of their own money on 40,779 shares at $9, growing their stake 2%.
+$356.4K
40,779 sh @ $9
JAZZ
Sebulsky Alan, JAZZ's Director, spent $90.2K of their own money on 5,212 shares at $17, growing their stake 39%.
+$90.2K
5,212 sh @ $17
Advertisement
About JAZZ insider activity
This page tracks every recent Form 4 filed for Jazz Pharmaceuticals plc with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is JAZZ insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Jazz Pharmaceuticals plc usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.